Patents by Inventor Hal GERBER

Hal GERBER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for treating testicular and ovarian adrenal rest tumors
    Patent number: 12576084
    Abstract: Provided herein are compounds and pharmaceutical compositions for the prevention and treatment of testicular adrenal rest tumors (TART) or ovarian adrenal rest tumors (OART).
    Type: Grant
    Filed: January 31, 2025
    Date of Patent: March 17, 2026
    Assignee: SPRUCE BIOSCIENCES, INC.
    Inventors: Alexis Howerton, Hal Gerber
  • Methods for treating testicular and ovarian adrenal rest tumors
    Patent number: 12569490
    Abstract: Provided herein are compounds and pharmaceutical compositions for the prevention and treatment of testicular adrenal rest tumors (TART) or ovarian adrenal rest tumors (OART).
    Type: Grant
    Filed: January 31, 2025
    Date of Patent: March 10, 2026
    Assignee: SPRUCE BIOSCIENCES, INC.
    Inventors: Alexis Howerton, Hal Gerber
  • Methods for treating testicular and ovarian adrenal rest tumors
    Patent number: 12569491
    Abstract: Provided herein are compounds and pharmaceutical compositions for the prevention and treatment of testicular adrenal rest tumors (TART) or ovarian adrenal rest tumors (OART).
    Type: Grant
    Filed: January 31, 2025
    Date of Patent: March 10, 2026
    Assignee: SPRUCE BIOSCIENCES, INC.
    Inventors: Alexis Howerton, Hal Gerber
  • METHODS FOR TREATING TESTICULAR AND OVARIAN ADRENAL REST TUMORS
    Publication number: 20250195527
    Abstract: Provided herein are compounds and pharmaceutical compositions for the prevention and treatment of testicular adrenal rest tumors (TART) or ovarian adrenal rest tumors (OART).
    Type: Application
    Filed: January 31, 2025
    Publication date: June 19, 2025
    Inventors: Alexis HOWERTON, Hal GERBER
  • METHODS FOR TREATING TESTICULAR AND OVARIAN ADRENAL REST TUMORS
    Publication number: 20250177404
    Abstract: Provided herein are compounds and pharmaceutical compositions for the prevention and treatment of testicular adrenal rest tumors (TART) or ovarian adrenal rest tumors (OART).
    Type: Application
    Filed: January 31, 2025
    Publication date: June 5, 2025
    Inventors: Alexis HOWERTON, Hal GERBER
  • METHODS FOR TREATING TESTICULAR AND OVARIAN ADRENAL REST TUMORS
    Publication number: 20250177403
    Abstract: Provided herein are compounds and pharmaceutical compositions for the prevention and treatment of testicular adrenal rest tumors (TART) or ovarian adrenal rest tumors (OART).
    Type: Application
    Filed: January 31, 2025
    Publication date: June 5, 2025
    Inventors: Alexis HOWERTON, Hal GERBER
  • METHODS FOR TREATING TESTICULAR AND OVARIAN ADRENAL REST TUMORS
    Publication number: 20250064812
    Abstract: Provided herein are compounds and pharmaceutical compositions for the prevention and treatment of testicular adrenal rest tumors (TART) or ovarian adrenal rest tumors (OART).
    Type: Application
    Filed: November 8, 2024
    Publication date: February 27, 2025
    Inventors: Alexis HOWERTON, Hal GERBER
  • Corticotropin releasing factor receptor antagonists
    Patent number: 12115166
    Abstract: The present invention provides novel pharmaceutical compositions comprising -(4-Chloro-2-(morpholin-4-yl)thiazol-5-yl)-7-(1-ethylpropyl)-2,5-dimethylpyrazolo(1,5-a)pyrimidine and methods of using the same for the treatment of Congenital adrenal hyperplasia (CAH).
    Type: Grant
    Filed: April 26, 2023
    Date of Patent: October 15, 2024
    Assignee: SPRUCE BIOSCIENCES, INC.
    Inventors: Alexis Howerton, Hal Gerber, Michael Huang
  • Corticotropin releasing factor receptor antagonists
    Patent number: 12005065
    Abstract: The present invention provides novel pharmaceutical compositions comprising -(4-Chloro-2-(morpholin-4-yl)thiazol-5-yl)-7-(1-ethylpropyl)-2,5-dimethylpyrazolo(1,5-a)pyrimidine and methods of using the same for the treatment of Congenital adrenal hyperplasia (CAH).
    Type: Grant
    Filed: April 26, 2023
    Date of Patent: June 11, 2024
    Assignee: Spruce Biosciences, Inc.
    Inventors: Alexis Howerton, Hal Gerber, Michael Huang
  • CORTICOTROPIN RELEASING FACTOR RECEPTOR ANTAGONISTS
    Publication number: 20230414627
    Abstract: The present invention provides novel pharmaceutical compositions comprising -(4-Chloro-2-(morpholin-4-yl)thiazol-5-yl)-7-(1-ethylpropyl)-2,5-dimethylpyrazolo(1,5-a)pyrimidine and methods of using the same for the treatment of Congenital adrenal hyperplasia (CAH).
    Type: Application
    Filed: April 26, 2023
    Publication date: December 28, 2023
    Inventors: Alexis HOWERTON, Hal GERBER, Michael HUANG
  • CORTICOTROPIN RELEASING FACTOR RECEPTOR ANTAGONISTS
    Publication number: 20230321112
    Abstract: The present invention provides novel pharmaceutical compositions comprising -(4-Chloro-2-(morpholin-4-yl)thiazol-5-yl)-7-(1-ethylpropyl)-2,5-dimethylpyrazolo(1,5-a)pyrimidine and methods of using the same for the treatment of Congenital adrenal hyperplasia (CAH).
    Type: Application
    Filed: December 9, 2022
    Publication date: October 12, 2023
    Inventors: Alexis HOWERTON, Hal GERBER, Michael HUANG
  • METHODS FOR TREATING TESTICULAR AND OVARIAN ADRENAL REST TUMORS
    Publication number: 20220211711
    Abstract: Provided herein are compounds and pharmaceutical compositions for the prevention and treatment of testicular adrenal rest tumors (TART) or ovarian adrenal rest tumors (OART).
    Type: Application
    Filed: February 8, 2022
    Publication date: July 7, 2022
    Inventors: Alexis HOWERTON, Hal GERBER
  • Corticotropin releasing factor receptor antagonists
    Patent number: 11351177
    Abstract: The present invention provides novel pharmaceutical compositions comprising-(4-Chloro-2-(morpholin-4-yl)thiazol-5-yl)-7-(1-ethylpropyl)-2,5-dimethylpyrazolo(1,5-a)pyrimidine and methods of using the same for the treatment of Congenital adrenal hyperplasia (CAH).
    Type: Grant
    Filed: June 25, 2021
    Date of Patent: June 7, 2022
    Assignee: Spruce Biosciences, Inc.
    Inventors: Alexis Howerton, Hal Gerber, Michael Huang
  • Corticotropin releasing factor receptor antagonists
    Patent number: 11344557
    Abstract: The present invention provides novel pharmaceutical compositions comprising -(4-Chloro-2-(morpholin-4-yl)thiazol-5-yl)-7-(1-ethylpropyl)-2,5-dimethylpyrazolo(1,5-a)pyrimidine and methods of using the same for the treatment of Congenital adrenal hyperplasia (CAH).
    Type: Grant
    Filed: October 5, 2020
    Date of Patent: May 31, 2022
    Assignee: Spruce Biosciences, Inc.
    Inventors: Alexis Howerton, Hal Gerber, Michael Huang
  • CORTICOTROPIN RELEASING FACTOR RECEPTOR ANTAGONISTS
    Publication number: 20220143037
    Abstract: The present invention provides novel pharmaceutical compositions comprising -(4-Chloro-2-(morpholin-4-yl)thiazol-5-yl)-7-(1-ethylpropyl)-2,5-dimethylpyrazolo(1,5-a)pyrimidine and methods of using the same for the treatment of Congenital adrenal hyperplasia (CAH).
    Type: Application
    Filed: January 27, 2022
    Publication date: May 12, 2022
    Inventors: Alexis HOWERTON, Hal GERBER, Michael HUANG
  • Corticotropin releasing factor receptor antagonists
    Patent number: 11311549
    Abstract: The present invention provides novel pharmaceutical compositions comprising -(4-Chloro-2-(morpholin-4-yl)thiazol-5-yl)-7-(1-ethylpropyl)-2,5-dimethylpyrazolo(1,5-a)pyrimidine and methods of using the same for the treatment of Congenital adrenal hyperplasia (CAH).
    Type: Grant
    Filed: June 25, 2021
    Date of Patent: April 26, 2022
    Assignee: SPRUCE BIOSCIENCES, INC.
    Inventors: Alexis Howerton, Hal Gerber, Michael Huang
  • Methods for treating testicular and ovarian adrenal rest tumors
    Patent number: 11304950
    Abstract: Provided herein are compounds and pharmaceutical compositions for the prevention and treatment of testicular adrenal rest tumors (TART) or ovarian adrenal rest tumors (OART).
    Type: Grant
    Filed: October 27, 2020
    Date of Patent: April 19, 2022
    Assignee: SPRUCE BIOSCIENCES, INC.
    Inventors: Alexis Howerton, Hal Gerber
  • CORTICOTROPIN RELEASING FACTOR RECEPTOR ANTAGONISTS
    Publication number: 20210361664
    Abstract: The present invention provides novel pharmaceutical compositions comprising -(4-Chloro-2-(morpholin-4-yl)thiazol-5-yl)-7-(1-ethylpropyl)-2,5-dimethylpyrazolo(1,5-a)pyrimidine and methods of using the same for the treatment of Congenital adrenal hyperplasia (CAH).
    Type: Application
    Filed: August 14, 2018
    Publication date: November 25, 2021
    Inventors: Alexis HOWERTON, Hal GERBER, Michael HUANG
  • CORTICOTROPIN RELEASING FACTOR RECEPTOR ANTAGONISTS
    Publication number: 20210322430
    Abstract: The present invention provides novel pharmaceutical compositions comprising -(4-Chloro-2-(morpholin-4-yl)thiazol-5-yl)-7-(1-ethylpropyl)-2,5-dimethylpyrazolo(1,5-a)pyrimidine and methods of using the same for the treatment of Congenital adrenal hyperplasia (CAH).
    Type: Application
    Filed: June 25, 2021
    Publication date: October 21, 2021
    Inventors: Alexis HOWERTON, Hal GERBER, Michael HUANG
  • CORTICOTROPIN RELEASING FACTOR RECEPTOR ANTAGONISTS
    Publication number: 20210322431
    Abstract: The present invention provides novel pharmaceutical compositions comprising -(4-Chloro-2-(morpholin-4-yl)thiazol-5-yl)-7-(1-ethylpropyl)-2,5-dimethylpyrazolo(1,5-a)pyrimidine and methods of using the same for the treatment of Congenital adrenal hyperplasia (CAH).
    Type: Application
    Filed: June 25, 2021
    Publication date: October 21, 2021
    Inventors: Alexis HOWERTON, Hal GERBER, Michael HUANG